Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15314185 | 1.00 | ALDH1A1 (0.53) | ALDH1A1HSD17B10GAAKDM4ELMNA | |
| SCHEMBL228037 | 1.00 | ALDH1A1 (0.53) | ALDH1A1HSD17B10GAAKDM4ELMNA | |
| SCHEMBL31315628 | 1.00 | ALDH1A1 (0.53) | ALDH1A1HSD17B10GAAKDM4ELMNA | |
| SCHEMBL29791776 | 0.78 | ALDH1A1 (0.59) | ALDH1A1HSD17B10GAAKDM4EMEN1 | |
| SCHEMBL17769033 | 0.78 | TYMS (0.48) | ALDH1A1HSD17B10KDM4EMEN1KMT2A | |
| SCHEMBL21881721 | 0.77 | APEX1 (0.38) | ALDH1A1GAAKDM4ELMNAMEN1 | |
| SCHEMBL11109865 | 0.76 | MAOB (0.45) | ALDH1A1HSD17B10KDM4E | |
| SCHEMBL18705354 | 0.76 | MAOA (0.35) | ALDH1A1HSD17B10KDM4EMEN1KMT2A | |
| SCHEMBL23771080 | 0.75 | POLB (0.39) | ALDH1A1HSD17B10GAAKDM4EMEN1 | |
| SCHEMBL31084351 | 0.75 | POLB (0.39) | ALDH1A1HSD17B10GAAKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118373791-A | Allyl phthalide compound and preparation method and application thereof | 南京工业大学 | 2024-07-23 | — | — | CN | claimed |
| CN-108794405-B | Method for continuously preparing Olaparib intermediate by adopting micro-channel modular reaction device | 南京工业大学 | 2020-09-04 | — | — | CN | claimed |
| WO-2025089351-A1 | RESIST COMPOSITION, RESIST PATTERN FORMING METHOD, COMPOUND, AND POLYMER COMPOUND | 東京応化工業株式会社 | 2025-05-01 | — | — | WO | disclosed |
| CN-119192108-A | Preparation method of chiral phthaloyl ester prodrug | 贵州大学 | 2024-12-27 | — | — | CN | disclosed |
| WO-2024210024-A1 | RESIST COMPOSITION, RESIST PATTERN FORMATION METHOD, COMPOUND, AND POLYMER COMPOUND | 東京応化工業株式会社 | 2024-10-10 | — | — | WO | disclosed |
| US-20240327375-A1 | SUBSTITUTED HETEROBICYCLIC DERIVATIVES AS NEGATIVE ALLOSTERIC MODULATORS OF MGLU7 RECEPTOR | ADDEX PHARMA S.A. (CH) | 2024-10-03 | — | — | US | disclosed |
| CN-118373791-A | Allyl phthalide compound and preparation method and application thereof | 南京工业大学 | 2024-07-23 | — | — | CN | disclosed |
| US-12037443-B2 | Polymeric materials with improved environmental durability | Westlake Royal Building Products Inc. (US) | 2024-07-16 | — | — | US | disclosed |
| US-12037304-B2 | Monomer and polymer, compensation film, optical film, and display device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-07-16 | — | — | US | disclosed |
| EP-4337643-A1 | SUBSTITUTED HETEROBICYCLIC DERIVATIVES AS NEGATIVE ALLOSTERIC MODULATORS OF MGLU7 RECEPTOR | Addex Pharma S.A (CH) | 2024-03-20 | — | — | EP | disclosed |
| US-11919857-B2 | Phthalide derivative, preparation method and use thereof | LANZHOU INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES (CN) | 2024-03-05 | — | — | US | disclosed |
| US-7196085-B2 | Phthalazinone derivatives | KUDOS PHARMACEUTICALS LIMITED (GB) | 2007-03-27 | — | — | US | disclosed |
| US-7196085-B2 | Phthalazinone derivatives | KUDOS PHARMACEUTICALS LIMITED (GB) | 2007-03-27 | — | — | US | disclosed |
| US-20070031514-A1 | Use of isoindolinone derivatives as insecticides | BAYER CROPSCIENCE AG (DE) | 2007-02-08 | — | — | US | disclosed |
| US-20070031514-A1 | Use of isoindolinone derivatives as insecticides | BAYER CROPSCIENCE AG (DE) | 2007-02-08 | — | — | US | disclosed |
| US-20070027147-A1 | Biarylurea derivatives | MSD K.K. (JP) | 2007-02-01 | — | — | US | disclosed |
| WO-2006021801-A1 | 4-HETEROARYLMETHYL SUBSTITUTED PHTHALAZINONE DERIVATIVES | KUDOS PHARMACEUTICALS LIMITED (GB) | 2006-03-02 | — | — | WO | disclosed |
| CN-1675212-A | 8- [ 3-amino-piperidin-1-yl ] -xanthines, process for their preparation and their use as pharmaceutical preparations | BOEHRINGER INGELHEIM PHARMA (DE) | 2005-09-28 | — | — | CN | disclosed |
| WO-2004080976-A1 | PHTHALAZINONE DERIVATIVES | KUDOS PHARMACEUTICALS LIMITED (GB) | 2004-09-23 | — | — | WO | disclosed |
| CN-1492870-A | Xanthine derivatives, process for their preparation and their use as pharmaceutical compositions | ���ָ��Ӣ��ķ�������Ϲ�˾ | 2004-04-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070031514-A1 | Use of isoindolinone derivatives as insecticides | DDT, CYP1A2, CYP1A1 | ALDH1A1 47/4885HSD17B10 821/4885GAA 4457/4885 |
| US-20070027147-A1 | Biarylurea derivatives | CDK6, CDK4, CCNI | ALDH1A1 935/4885HSD17B10 1895/4885GAA 3502/4885 |
| US-11919857-B2 | Phthalide derivative, preparation method and use thereof | HDAC6, NQO1, UGT2B7 | ALDH1A1 125/4885HSD17B10 220/4885GAA 566/4885 |
| US-20240327375-A1 | SUBSTITUTED HETEROBICYCLIC DERIVATIVES AS NEGATIVE ALLOSTERIC MODULATORS OF MGLU7 RECEPTOR | GRM7, GRM2, GRM1 | ALDH1A1 3508/4885HSD17B10 3270/4885GAA 4270/4885 |
| US-12037304-B2 | Monomer and polymer, compensation film, optical film, and display device | PYM1, RAD51, CRY1 | ALDH1A1 326/4885HSD17B10 4593/4885GAA 3927/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.